Comparison of the use of a foot pump with the use of low-molecular- weight heparin for the prevention of deep-vein thrombosis after total hip replacement: A prospective, randomized trial

Journal of Bone and Joint Surgery

Volumn 80, Issue 8, 1998, Pages 1158-1166

  Warwick, David ^a   Harrison, Jeffrey ^b   Glew, David ^c   Mitchelmore, Andrew ^c   Peters, Tim J ^d   Donovan, Jenny ^d  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b Avon Orthopaedic Centre   (United Kingdom)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; FOOT; HEMATOMA; HUMAN; LEG EDEMA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PHLEBOGRAPHY; PREVALENCE; PRIORITY JOURNAL; PUMP; RANDOMIZED CONTROLLED TRIAL; SOFT TISSUE DISEASE; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS; WOUND DRAINAGE;

EID: 0031696733     PISSN: 00219355     EISSN: None     Source Type: Journal    
DOI: 10.2106/00004623-199808000-00009     Document Type: Article

References (39)

1. Altman, D. G.: Better reporting of randomised controlled trials: the CONSORT statement. Authors must provide enough information for readers to know how the trial was performed. British Med. J., 313: 570-571, 1996.
2. Andrews, B. T.; Sommerville, K.; Wilson, N.; and Browse, N. L.: The effect of foot compression on the velocity and volume of blood flow in the deep veins. British J. Surg., 80: 198-200, 1993.
3. Bergovist, D.; Benoni, G.; Björgell, O.; Fredin, H.; Hedlundh, U.; Nicolas, S.; Nilsson, P.; and Nylander, G.: Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. New England J. Med., 335: 696-700, 1996.
4. Bradley, J. G.; Krugener, G. H.; and Jager, H. J.: The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. J. Arthroplasty, 8: 57-61, 1993.
5. Comerota, A. J.; Katz, M. L.; and White, J. V.: Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail? Am. J. Surg., 164: 265-268, 1992.
6. Dahl, O. E.; Andreassen, G.; Aspelin, T.; Muller, C.; Mathiesen, P.; Nyhus, S.; Abdelnoor, M.; Solhaug, J. H.; and Arnesen, H.: Prolonged thromboprophylaxis following hip replacement surgery - results of a double-blind, prospective, randomized placebo-controlled study with dalteparin (Fragmin). Thromb. and Haemost., 77: 26-31, 1997.
7. Fleming, T. R., and DeMets, D. L.: Surrogate end points in clinical trials: are we being misled? Ann. Intern. Med., 125: 605-613, 1996.
8. Fordyce, M. J. F., and Ling, R. S. M.: A venous foot pump reduces thrombosis after total hip replacement. J. Bone and Joint Surg., 74-B(1): 45-49, 1992.
9. Gardner, A. M., and Fox, R. H.: The venous pump of the human foot - preliminary report. Bristol Med.-Chir. J., 98: 109-112, 1983.
10. Gardner, A. M. N., and Fox, R. H.: The Return of Blood to the Heart: Venous Pumps in Health and Disease. London, Libbey, 1989.
11. Heit, J. A.; Berkowitz, S. D.; Bona, R.; Cabanas, V.; Corson, J. D.; Elliott, C. G.; Lyons, R.; and the Ardeparin Arthroplasty Study Group: Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study. Thromb. and Haemost., 77: 32-38, 1997.
12. Hui, A. C. W.; Heras-Palou, C.; Dunn, I.; Triffitt, P. D.; Crozier, A.; Imeson, J.; and Gregg, P. J.: Graded compression stockings for prevention of deep-vein thrombosis after hip and knee replacement. J. Bone and Joint Surg., 78-B(4): 550-554, 1996.
13. Huo, M. H.; Salvati, E. A.; Sharrock, N. E.; Brien, W. W.; Sculco, T. P.; Pellicci, P. M.; Mineo, R.; and Go, G.: Intraoperative heparin thromboembolic prophylaxis in primary total hip arthroplasty. A prospective, randomized, controlled, clinical trial. Clin. Orthop., 274: 35-46, 1992.
14. International Consensus Statement Prevention of venous thromboembolism. Internat. Angiol., 15: 1-36, 1997.
15. Jones, B.; Jarvis, P.; Lewis, J. A.; and Ebbutt, A. F.: Trials to assess equivalence: the importance of rigorous methods. British Med. J., 313: 36-39, 1996.
16. Killewich, L. A.; Sandager, G. P.; Nguyen, A. H.; Lilly, M. P.; and Flinn, W. R.: Venous hemodynamics during impulse foot pumping. J. Vasc. Surg., 22: 598-605, 1995.
17. Landefeld, C. S.; Cook, E. F.; Flatley, M.; Weisberg, M.; and Goldman, L.: Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy. Am. J. Med., 82: 703-713, 1987.
18. Leizorovicz, A.; Haugh, M. C.; Chapuis, F. R.; Samama, M. M.; and Boissel, J. P.: Low molecular weight heparin in prevention of perioperative thrombosis. British Med. J., 305: 913-920, 1992.
19. McNally, M. A., and Mollan, R. A. B.: Total hip replacement, lower limb blood flow and venous thrombogenesis. J. Bone and Joint Surg., 75-B(4): 640-644, 1993.
20. McNally, M. A.; McAlinden, M. G.; O'Connell, B. M.; and Mollan, R. A.: Postphlebitic syndrome after hip arthroplasty. 43 patients followed at least 5 years. Acta Orthop. Scandinavica, 65: 595-598, 1994.
21. Moser, K. M., and LeMoine, J. R.: Is embolic risk conditioned by location of deep venous thrombosis? Ann. Intern. Med., 94: 439-444, 1981.
22. Murray, D. W.; Britton, A. R.; and Bulstrode, C. J. K.: Thromboprophylaxis and death after total hip replacement. J. Bone and Joint Surg., 78-B(6): 863-870, 1996.
23. Oishi, C. S.; Grady-Benson, J. C.; Otis, S. M.; Colwell, C. W., Jr.; and Walker, R. H.: The clinical course of distal deep venous thrombosis after total hip and total knee arthroplasty, as determined with duplex ultrasonography. J. Bone and Joint Surg., 76-A: 1658-1663, Nov. 1994.
24. Planes, A.; Vochelle, N.; Darmon, J. Y.; Fagola, M.; Bellaud, M.; and Huet, Y.: Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomized comparison of enoxaparin versus placebo. Lancet, 348: 224-228, 1996.
25. Prins, M. H., and Hirsh, J.: A comparison of general anesthesia and regional anesthesia as a risk factor for deep vein thrombosis following hip surgery; a critical review. Thromb. and Haemost., 64: 497-500, 1990.
26. The RD Heparin Arthroplasty Group: RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. J. Bone and Joint Surg., 76-A: 1174-1185, Aug. 1994.
27. Ricotta, S.; Iorio, A.; Parise, P.; Nenci, G. G.; and Agnelli, G.: Post discharge clinically overt venous thromboembolism in orthopaedic surgery patients with negative venography - an overview analysis. Thromb. and Haemost., 76: 887-892, 1996.
28. Santori, E. S.; Vitullo, A.; Stopponi, M.; Santori, N.; and Ghera, S.: Prophylaxis against deep-vein thrombosis in total hip replacement. J. Bone and Joint Surg., 76-B(4): 579-583, 1994.
29. Seagroatt, V.; Tan, H. S.; Goldacre, M.; Bulstrode, C.; Nugent, I.; and Gill, L.: Elective total hip replacement: incidence, emergency readmission rate, and postoperative mortality. British Med. J., 303: 1431-1435, 1991.
30. Stranks, G. J.; McKenzie, N. A.; Grover, M. L.; and Fail, T.: The A-V Impulse System reduces deep-vein thrombosis and swelling after hemiarthroplasty for hip fracture. J. Bone and Joint Surg., 74-B(5): 775-778, 1992.
31. Warwick, D.; Williams, M. H.; and Bannister, G. C.: Death and thromboembolic disease after total hip replacement. A series of 1162 cases with no routine chemical prophylaxis. J. Bone and Joint Surg., 77-B(1): 6-10, 1995.
32. Warwick, D.; Martin, A. G.; Glew, D.; and Bannister, G. C.: Measurement of femoral vein blood flow during total hip replacement. Duplex ultrasound imaging with and without the use of a foot pump. J. Bone and Joint Surg., 76-B(6): 918-921, 1994.
33. Warwick, D.; Perez, J.; Vickery, C.; and Bannister, G.: Does total hip arthroplasty predispose to chronic venous insufficiency? J. Arthroplasty, 11: 529-533, 1996.
34. Warwick, D.; Bannister, G. C.; Glew, D.; Mitchelmore, A.; Thornton, M.; Peters, T. J.; and Brookes, S.: Perioperative low-molecular-weight heparin. Is it effective and safe? J. Bone and Joint Surg., 77-B(5): 715-719, 1995.
35. Wells, P. S.; Lensing, A. W.; Davidson, B. L.; Prins M. H.; and Hirsh, J.: Accuracy of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic patients after orthopaedic operation. A meta-analysis. Ann. Intern. Med., 122: 47-53, 1995.
36. Westrich, G. H., and Sculco, T. P.: Prophylaxis against deep venous thrombosis after total knee arthroplasty. Pneumatic plantar compression and aspirin compared with aspirin alone. J. Bone and Joint Surg., 78-A: 826-834, June 1996.
37. Wilson, N. V.; Das, S. K.; Kakkar, V. V.; Maurice, H. D.; Smibert, J. G.; Thomas, E. M.; and Nixon, J. E.: Thromboembolic prophylaxis in total knee replacement. J. Bone and Joint Surg., 74-B(1): 50-52, 1992.
38. Woolson, S. T.: The resolution of deep venous thrombosis that occurs after total joint arthroplasty. A study of thrombi treated with anticoagulation and observed by repeat venous ultrasound scans. Clin. Orthop., 299: 86-91, 1994.
39. Woolson, S. T.: Intermittent pneumatic compression prophylaxis for proximal deep venous thrombosis after total hip replacement. J. Bone and Joint Surg., 78-A: 1735-1740, Nov. 1996.